Technology that predicts if a patient will become unstable hours before traditional vital signs is now backed with an $11.5 million Series A investment. Fifth Eye Inc., a Michigan Medicine spinoff medical device software company started in 2017, received the investment to support research, development and commercialization of the company’s first product: the Analytic for Hemodynamic Instability (AHI).

The University of Michigan introduced a new study to investigate the relationship between biosensors and health results earlier this month, following a pilot program in September. The Michigan Predictive Activity and Clinical Trajectories (MIPACT) study…